These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 33091548)

  • 1. Variant analysis of the first Lebanese SARS-CoV-2 isolates.
    Abou-Hamdan M; Hamze K; Abdel Sater A; Akl H; El-Zein N; Dandache I; Abdel-Sater F
    Genomics; 2021 Jan; 113(1 Pt 2):892-895. PubMed ID: 33091548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variant analysis of SARS-CoV-2 genomes in the Middle East.
    Bindayna KM; Crinion S
    Microb Pathog; 2021 Apr; 153():104741. PubMed ID: 33588026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome sequencing of SARS-CoV-2 in a cohort of Egyptian patients revealed mutation hotspots that are related to clinical outcomes.
    Zekri AN; Mohanad M; Hafez MM; Soliman HK; Hassan ZK; Abouelhoda M; Amer KE; Seadawy MG; Ahmed OS
    Biochim Biophys Acta Mol Basis Dis; 2021 Aug; 1867(8):166154. PubMed ID: 33932525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome sequence diversity of SARS-CoV-2 obtained from clinical samples in Uzbekistan.
    Abdullaev A; Abdurakhimov A; Mirakbarova Z; Ibragimova S; Tsoy V; Nuriddinov S; Dalimova D; Turdikulova S; Abdurakhmonov I
    PLoS One; 2022; 17(6):e0270314. PubMed ID: 35759503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time Series Analysis of SARS-CoV-2 Genomes and Correlations among Highly Prevalent Mutations.
    Periwal N; Rathod SB; Sarma S; Johar GS; Jain A; Barnwal RP; Srivastava KR; Kaur B; Arora P; Sood V
    Microbiol Spectr; 2022 Oct; 10(5):e0121922. PubMed ID: 36069583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Genetic Variability in ACE2 Expression on the Evolutionary Dynamics of SARS-CoV-2 Spike D614G Mutation.
    Huang SW; Miller SO; Yen CH; Wang SF
    Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33374416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The extent of molecular variation in novel SARS-CoV-2 after the six-month global spread.
    Bui NN; Lin YT; Huang SH; Lin CW
    Infect Genet Evol; 2021 Jul; 91():104800. PubMed ID: 33677109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different selection dynamics of S and RdRp between SARS-CoV-2 genomes with and without the dominant mutations.
    Koçhan N; Eskier D; Suner A; Karakülah G; Oktay Y
    Infect Genet Evol; 2021 Jul; 91():104796. PubMed ID: 33667722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large-scale analysis of SARS-CoV-2 spike-glycoprotein mutants demonstrates the need for continuous screening of virus isolates.
    Schrörs B; Riesgo-Ferreiro P; Sorn P; Gudimella R; Bukur T; Rösler T; Löwer M; Sahin U
    PLoS One; 2021; 16(9):e0249254. PubMed ID: 34570776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of SARS-CoV-2 Envelope, Membrane, Nucleocapsid, and Spike Structural Proteins from the Beginning of the Pandemic to September 2020: A Global and Regional Approach by Epidemiological Week.
    Troyano-Hernáez P; Reinosa R; Holguín Á
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33557213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for mutations in SARS-CoV-2 Italian isolates potentially affecting virus transmission.
    Benvenuto D; Demir AB; Giovanetti M; Bianchi M; Angeletti S; Pascarella S; Cauda R; Ciccozzi M; Cassone A
    J Med Virol; 2020 Oct; 92(10):2232-2237. PubMed ID: 32492183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphic landscape of SARS-CoV-2 genomes isolated from Indian population in 2020 demonstrates rapid evolution in ORF3a, ORF8, nucleocapsid phosphoprotein and spike glycoprotein.
    Pal A; Dobhal S; Dey KK; Sharma AK; Savani V; Negi VS
    Comput Biol Chem; 2021 Dec; 95():107594. PubMed ID: 34736125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolutionary and Phenotypic Characterization of Two Spike Mutations in European Lineage 20E of SARS-CoV-2.
    Ruiz-Rodriguez P; Francés-Gómez C; Chiner-Oms Á; López MG; Jiménez-Serrano S; Cancino-Muñoz I; Ruiz-Hueso P; Torres-Puente M; Bracho MA; D'Auria G; Martinez-Priego L; Guerreiro M; Montero-Alonso M; Gómez MD; Piñana JL; ; González-Candelas F; Comas I; Marina A; Geller R; Coscolla M
    mBio; 2021 Dec; 12(6):e0231521. PubMed ID: 34781748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Gapless, Unambiguous RNA Metagenome-Assembled Genome Sequence of a Unique SARS-CoV-2 Variant Encoding Spike S813I and ORF1a A859V Substitutions.
    Soliman MS; AbdelFattah M; Aman SMN; Ibrahim LM; Aziz RK
    OMICS; 2021 Feb; 25(2):123-128. PubMed ID: 33253058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-genome sequencing of SARS-CoV-2 reveals the detection of G614 variant in Pakistan.
    Umair M; Ikram A; Salman M; Khurshid A; Alam M; Badar N; Suleman R; Tahir F; Sharif S; Montgomery J; Whitmer S; Klena J
    PLoS One; 2021; 16(3):e0248371. PubMed ID: 33755704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher entropy observed in SARS-CoV-2 genomes from the first COVID-19 wave in Pakistan.
    Ghanchi NK; Nasir A; Masood KI; Abidi SH; Mahmood SF; Kanji A; Razzak S; Khan W; Shahid S; Yameen M; Raza A; Ashraf J; Ansar Z; Dharejo MB; Islam N; Hasan Z; Hasan R
    PLoS One; 2021; 16(8):e0256451. PubMed ID: 34464419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-synonymous mutations of SARS-CoV-2 leads epitope loss and segregates its variants.
    Gupta AM; Chakrabarti J; Mandal S
    Microbes Infect; 2020; 22(10):598-607. PubMed ID: 33049387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteo-Genomic Analysis of SARS-CoV-2: A Clinical Landscape of Single-Nucleotide Polymorphisms, COVID-19 Proteome, and Host Responses.
    Tushir S; Kamanna S; Nath SS; Bhat A; Rose S; Aithal AR; Tatu U
    J Proteome Res; 2021 Mar; 20(3):1591-1601. PubMed ID: 33555895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular epidemiology analysis of early variants of SARS-CoV-2 reveals the potential impact of mutations P504L and Y541C (NSP13) in the clinical COVID-19 outcomes.
    Cao C; He L; Tian Y; Qin Y; Sun H; Ding W; Gui L; Wu P
    Infect Genet Evol; 2021 Aug; 92():104831. PubMed ID: 33798758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a High-Frequency Intrahost SARS-CoV-2 Spike Variant with Enhanced Cytopathic and Fusogenic Effects.
    Rocheleau L; Laroche G; Fu K; Stewart CM; Mohamud AO; Côté M; Giguère PM; Langlois MA; Pelchat M
    mBio; 2021 Jun; 12(3):e0078821. PubMed ID: 34182784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.